Asset Details
Do you wish to reserve the book?
Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment
Do you wish to request the book?
Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment
2021
Overview
The hepatitis A virus (HAV) is a leading cause of acute viral hepatitis worldwide. It is transmitted mainly by direct contact with patients who have been infected or by ingesting contaminated water or food. The virus is endemic in low-income countries where sanitary and sociodemographic conditions are poor. Paradoxically, improving sanitary conditions in these countries, which reduces the incidence of HAV infections, can lead to more severe disease in susceptible adults. The populations of developed countries are highly susceptible to HAV, and large outbreaks can occur when the virus is spread by globalization and by increased travel and movement of foodstuffs. Most of these outbreaks occur among high-risk groups: travellers, men who have sex with men, people who use substances, and people facing homelessness. Hepatitis A infections can be prevented by vaccination; safe and effective vaccines have been available for decades. Several countries have successfully introduced universal mass vaccination for children, but high-risk groups in high-income countries remain insufficiently protected. The development of HAV antivirals may be important to control HAV outbreaks in developed countries where a universal vaccination programme is not recommended.
Publisher
MDPI AG,MDPI
Subject
/ Antiviral Agents - pharmacology
/ Antiviral Agents - therapeutic use
/ Disease
/ Disease Outbreaks - prevention & control
/ Food contamination & poisoning
/ Hepatitis A - prevention & control
/ Hepatitis A virus - drug effects
/ Humans
/ Male
/ Review
/ Sexual and Gender Minorities
/ Travel
/ Viruses
